NCT05924139 (FO n-3) is a NA clinical trial of Omega-3 fatty acid in Strength, sponsored by Baylor University.

Who is sponsoring NCT05924139?

NCT05924139 is sponsored by Baylor University.

What drugs are being tested in NCT05924139?

Interventions in NCT05924139: Omega-3 fatty acid, Placebo.

What condition does NCT05924139 study?

NCT05924139 studies Strength, Body Composition, Muscle Soreness.

Is NCT05924139 still recruiting?

NCT05924139 is currently completed. Last updated 29 June 2023.

Last reviewed 2023-06-29 · How we verify

NCT05924139: FO n-3

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Omega-3 Fatty Acid Supplementation to Enhance Performance

Completed NA Last updated 29 June 2023

What this trial tests

NA trial testing Omega-3 fatty acid in Strength in 33 participants. Completed in 2 June 2023.

Timeline

6 March 2023

Primary endpoint
10 May 2023

2 June 2023

Quick facts

Lead sponsor	Baylor University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	33
Start date	6 March 2023
Primary completion	10 May 2023
Estimated completion	2 June 2023
Sites	1 location across United States

Drugs / interventions tested

Omega-3 fatty acid
Placebo

Conditions studied

Strength — all drugs for Strength →
Body Composition — all drugs for Body Composition →
Muscle Soreness — all drugs for Muscle Soreness →

Sponsor

Baylor University

Who can join

Adults 18 to 25, any sex, with Strength or Body Composition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this intervention study is to determine if omega-3 fatty acid supplementation as compared to placebo improves performance in track and field athletes. The main questions it aims to answer are: 1. Can performance be improved 2. Can strength be enhanced 3. Will positive body composition changes occur (lean vs fat mass) 4. Will feelings of muscle soreness be diminished Participants will take either omega-3 fatty acid supplements or placebo and continue with their sport specific training regimen. Researchers will compare the supplement group to placebo group to determine if there are any significant differences.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Omega-3 fatty acid

Trials testing the same drug.

NCT03120299 — The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN) · Phase 4 · completed
NCT01821833 — Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel · NA · completed
NCT01881048 — Window of Opportunity Study Targeting the Inflammatory Milieu · EARLY_PHASE1 · completed

Other recruiting trials for Strength

Currently open trials in the same condition.

NCT07343219 — Effects of Root Extract Ashwagandha (KSM-66) on Physiological Stress, Perception of Recovery and Muscle Strength in Yout · NA · active not recruiting
NCT07322653 — The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population · NA · recruiting
NCT06688279 — Effects of Plyometric Exercises in Female Fast Bowlers · NA · recruiting
NCT06438887 — Strategic Ingestion of Creatine Supplementation and Resistance Training in Trained Young Adults · NA · recruiting
NCT06218121 — Update on the Detection of Frailty in Older Adults · recruiting

Other Baylor University trials

Trials by the same sponsor.

NCT07452900 — Using Integrated Care and Wearable Technology to Evaluate Outcomes of the Shields & Stripes Program for Veterans and Fir · not yet recruiting
NCT07185737 — Culturally Adapted RUBI-T for Spanish-Speaking Families in Texas and Mexico · NA · not yet recruiting
NCT07460609 — Exploring Blood Flow Restriction as an Accessible Fitness Solution for Healthy Aging in Seniors · NA · active not recruiting
NCT06906107 — Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for Neck Pain Relief · NA · recruiting
NCT06739772 — Development of Implementation Toolkits · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05924139 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Baylor University
Last refreshed: 29 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05924139.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing